Assignee
SANOFI BIOTECHNOLOGY
FR·23 granted patents·46 pending applications·165 citations·filing 2012–2025
Top patents by PatentIndex Score
69 records- 0194US10066017B2Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonistSANOFI BIOTECHNOLOGY·Filed 2015·Granted Sep 4, 2018·25 cites·33 claims
- 0293US10137193B2Methods for treating or preventing asthma by administering an IL-4R antagonistSANOFI BIOTECHNOLOGY·Filed 2015·Granted Nov 27, 2018·31 cites·30 claims
- 0393US10059771B2Methods for treating nasal polyposis by administering an IL-4R antagonistSANOFI BIOTECHNOLOGY·Filed 2014·Granted Aug 28, 2018·26 cites·57 claims
- 0492US11246925B2Human antibodies to PCSK9 for use in methods of treating particular groups of subjectsSANOFI BIOTECHNOLOGY·Filed 2019·Granted Feb 15, 2022·5 cites·13 claims
- 0591US12083176B2Human antibodies to PCSK9 for use in methods of treating particular groups of subjectsSANOFI BIOTECHNOLOGY·Filed 2021·Granted Sep 10, 2024·1 cites·10 claims
- 0691US11306155B2Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibodySANOFI BIOTECHNOLOGY·Filed 2019·Granted Apr 19, 2022·5 cites·14 claims
- 0791US11034768B2Methods for treating or preventing asthma by administering an IL-4R antagonistSANOFI BIOTECHNOLOGY·Filed 2018·Granted Jun 15, 2021·19 cites·40 claims
- 0890US2026055198A1Methods for treating or preventing asthma by administering an il-4r antagonistSANOFI BIOTECHNOLOGY·Filed 2025·Application pending·0 cites
- 0988US11639392B2Anti-IL-1R3 antibodies for use in inflammatory conditionsSANOFI BIOTECHNOLOGY·Filed 2018·Granted May 2, 2023·5 cites·9 claims
- 1088US10544232B2Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibodySANOFI BIOTECHNOLOGY·Filed 2015·Granted Jan 28, 2020·9 cites·16 claims
- 1187US11845800B2Methods for treating or preventing asthma by administering an IL-4R antagonistSANOFI BIOTECHNOLOGY·Filed 2017·Granted Dec 19, 2023·4 cites·33 claims
- 1287US10927435B2Compositions for the treatment of rheumatoid arthritis and methods of using sameSANOFI BIOTECHNOLOGY·Filed 2012·Granted Feb 23, 2021·8 cites·18 claims
- 1387US2025064926A1Human antibodies to pcsk9 for use in methods of treating particular groups of subjectsSANOFI BIOTECHNOLOGY·Filed 2024·Application pending·0 cites
- 1486US12024564B2Humanized anti-IL-1R3 antibodiesSANOFI BIOTECHNOLOGY·Filed 2021·Granted Jul 2, 2024·1 cites·15 claims
- 1586US9943594B2Methods for the treatment of rheumatoid arthritisSANOFI BIOTECHNOLOGY·Filed 2012·Granted Apr 17, 2018·8 cites·13 claims
- 1684US11214621B2Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonistSANOFI BIOTECHNOLOGY·Filed 2018·Granted Jan 4, 2022·2 cites·39 claims
- 1784US10428157B2Dosing regimens for use with PCSK9 inhibitorsSANOFI BIOTECHNOLOGY·Filed 2014·Granted Oct 1, 2019·8 cites·13 claims
- 1882US12054552B2Humanized anti-IL-1R3 antibody and methods of useSANOFI BIOTECHNOLOGY·Filed 2023·Granted Aug 6, 2024·1 cites·22 claims
- 1982US2026007742A1Methods for treating digitally-identified il-4/il-13 related disorders by administering an anti-il4r-alpha antibodySANOFI BIOTECHNOLOGY·Filed 2025·Application pending·0 cites
- 2082US2025059300A1METHODS FOR TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (heFH) WITH AN ANTI-PCSK9 ANTIBODYSANOFI BIOTECHNOLOGY·Filed 2024·Application pending·0 cites
- 2180US11723974B2Methods for treating digitally identified IL-4/IL-13-related disorders by administering an anti-IL4R-alpha antibodySANOFI BIOTECHNOLOGY·Filed 2020·Granted Aug 15, 2023·1 cites·48 claims
- 2280US2024199751A1Methods for treating or preventing asthma by administering an il-4r antagonistSANOFI BIOTECHNOLOGY·Filed 2023·Application pending·0 cites
- 2379US12440562B2Method of treating an eye-related disorder by administering an anti-interleukin-4 receptor alpha (anti-IL-4Rα) antibodySANOFI BIOTECHNOLOGY·Filed 2023·Granted Oct 14, 2025·0 cites·18 claims
- 2477US11498969B2Compositions and methods for treating juvenile idiopathic arthritisSANOFI BIOTECHNOLOGY·Filed 2020·Granted Nov 15, 2022·2 cites·22 claims
- 2577US2024409644A1Humanized anti-il-1r3 antibodiesSANOFI BIOTECHNOLOGY·Filed 2024·Application pending·0 cites
- 2676US12398212B2Methods for treating or preventing asthma by administering an IL-4R antagonistSANOFI BIOTECHNOLOGY·Filed 2020·Granted Aug 26, 2025·1 cites·23 claims
- 2776US10968278B2Compositions comprising IL6R antibodies for the treatment of uveitis and macular edema and methods of using sameSANOFI BIOTECHNOLOGY·Filed 2016·Granted Apr 6, 2021·3 cites·24 claims
- 2874US2024000931A1Methods for treating digitally-identified il-4/il-13 related disorders by administering an anti-il4r-alpha antibodySANOFI BIOTECHNOLOGY·Filed 2023·Application pending·0 cites
- 2973US2022315669A1METHODS FOR TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (heFH) WITH AN ANTI-PCSK9 ANTIBODYSANOFI BIOTECHNOLOGY·Filed 2022·Application pending·0 cites
- 3073US2026027202A1Treatment of rheumatoid arthritis with an il-6r antibodySANOFI BIOTECHNOLOGY·Filed 2025·Application pending·0 cites
- 3172US2025154245A1Monoclonal anti-il-1racp antibodiesSANOFI BIOTECHNOLOGY·Filed 2025·Application pending·0 cites
- 3269US2023383000A1Anti-il-1r3 antibodies for use in inflammatory conditionsSANOFI BIOTECHNOLOGY·Filed 2023·Application pending·0 cites
- 3369US2022204631A1Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonistSANOFI BIOTECHNOLOGY·Filed 2021·Application pending·0 cites
- 3467US2017340515A1Pharmaceutical compositions comprising human antibodies to pcsk9SANOFI BIOTECHNOLOGY·Filed 2017·Application pending·0 cites
- 3565US2025019452A1Humanized anti-il-1r3 antibody and methods of useSANOFI BIOTECHNOLOGY·Filed 2024·Application pending·0 cites
- 3664US2021322546A1Methods for treating or preventing asthma by administering an il-4r antagonistSANOFI BIOTECHNOLOGY·Filed 2021·Application pending·0 cites
- 3764US2026049150A1Methods for treating or preventing asthma by administering an il-4r antagonistSANOFI BIOTECHNOLOGY·Filed 2025·Application pending·0 cites
- 3862US2020255544A1Methods for treating high cardiovascular risk patients with hypercholesterolemiaSANOFI BIOTECHNOLOGY·Filed 2019·Application pending·0 cites
- 3961US2021230719A1Compositions for the treatment of rheumatoid arthritis and methods of using sameSANOFI BIOTECHNOLOGY·Filed 2020·Application pending·0 cites
- 4061US2022144969A1Methods for reducing cardiovascular riskSANOFI BIOTECHNOLOGY·Filed 2021·Application pending·0 cites
- 4160US2021380705A1Methods for treating or preventing asthma by administering an il-4r antagonistSANOFI BIOTECHNOLOGY·Filed 2021·Application pending·0 cites
- 4260US2017266079A1Human antibodies to pcsk9 for use in methods of treating particular groups of subjectsSANOFI BIOTECHNOLOGY·Filed 2016·Application pending·0 cites
- 4359US2023183362A1Methods for treating prurigo nodularis by administering an il-4r antagonistSANOFI BIOTECHNOLOGY·Filed 2022·Application pending·0 cites
- 4459US2024360232A1Methods for treating chronic obstructive pulmonary disease (copd) by administering an il-4r antagonistSANOFI BIOTECHNOLOGY·Filed 2024·Application pending·0 cites
- 4557US2023146317A1Methods for treating chronic spontaneous urticaria by administering an il-4r antagonistSANOFI BIOTECHNOLOGY·Filed 2022·Application pending·0 cites
- 4656US2023399410A1Compositions and methods for treating polymyalgia rheumatica by administering an il-6r antagonistSANOFI BIOTECHNOLOGY·Filed 2023·Application pending·0 cites
- 4756US2023127528A1Compositions and methods for treating juvenile idiopathic arthritisSANOFI BIOTECHNOLOGY·Filed 2022·Application pending·0 cites
- 4853US2019125865A1Methods for treating or preventing asthma by administering an il-4r antagonistSANOFI BIOTECHNOLOGY·Filed 2018·Application pending·0 cites
- 4953US2018296670A1Compositions for the treatment of rheumatoid arthritis and methods of using sameSANOFI BIOTECHNOLOGY·Filed 2018·Application pending·0 cites
- 5053US2025333522A1Compositions and methods for treating pain in subjects with rheumatoid arthritisSANOFI BIOTECHNOLOGY·Filed 2025·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SANOFI BIOTECHNOLOGY files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →